Skip to content

Effect of cumin on blood fat and body composition in obese women

Efficacy of Cumin on Lipid profile and and body composition in overweight and obese women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013021112429N1
Enrollment
100
Registered
2013-05-21
Start date
2013-01-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: hyperlipidaemia. Condition 2: OBESITY. Disorders of lipoprotein metabolism Simple obesity NOS

Interventions

Intervention 1: The intervention group, will be asked to eat 3 grams cumin powder with yogurt for lunch and dinner, two times (each time 1/5 grams cumin + 150 ml low-fat yogurt.) Reduced calorie di
Treatment - Drugs
The intervention group, will be asked to eat 3 grams cumin powder with yogurt for lunch and dinner, two times (each time 1/5 grams cumin + 150 ml low-fat yogurt.) Reduced calorie diet (300 kcal les
in control group: reduced calorie diet (300 kcal less than the amount necessary) to be given by a nutrition Specialist.they asked to eat 150 ml low-fat yogurt ,twice a they with out cumin.Period of

Sponsors

Department of Research and Technology, Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with BMI 25-40; consent to participate in the study ;No previous treatment regimen for three months before entering the study; no change in weight over 2 kg in a month prior to entering the study; lack of sensitivity to the Cumin, non-infectious diseases, diabetes, hypertension, thyroid disease and other chronic diseases based on self-declaration ; age 20-60 years Exclusion criteria: failure to cooperate in the study; the history of the program regimen; change in weight over 2 kg in the last month; allergic reactions of cumin; Disease during the study, or a history of chronic disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fbs. Timepoint: 3 month. Method of measurement: blood sample.;Bmi. Timepoint: 3 month. Method of measurement: w/h2.;Tg. Timepoint: 3 month. Method of measurement: blood sample.;Col. Timepoint: 3month. Method of measurement: blood sample.;LDL-C. Timepoint: 3 month. Method of measurement: blood sample.;HDL-C. Timepoint: 3 month. Method of measurement: blood sample.;LDL/HDL. Timepoint: 3 month. Method of measurement: blood sample.;COL/HDL. Timepoint: 3 month. Method of measurement: blood sample.;VLDL. Timepoint: 3 month. Method of measurement: blood sample.;Weight. Timepoint: every month until 3 month. Method of measurement: .;Waist size. Timepoint: 3 month. Method of measurement: cm.;Fat mass. Timepoint: 3 month. Method of measurement: body composition analizer.;Free body mascle. Timepoint: 3 month. Method of measurement: body composition analizer.;Percent of fat mass. Timepoint: 3 month. Method of measurement: body composition analizer.;Percent of free mascle mass. Timepoint: 3 month. Method of measurement: body composition analizer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoghayeh Zare

Nutrition and Food Security Research Centre

R_ZARE1391@SSU.AC.IR+98 35 1624 0691

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026